MedPath

Role of Homoeopathy In Prostatic Complaints

Phase 3
Not yet recruiting
Conditions
Benign prostatic hyperplasia,
Registration Number
CTRI/2023/06/053956
Lead Sponsor
Dr MPK Homoepathic Medical College Hospital and Research Center
Brief Summary

This study is a prospective, interventional, parallel arm, comparative study of the efficacy of Homoeopathic medicines selected on the basis of the totality of symptoms and pathological similie in the cases of Benign Prostatic Hyperplasia

The primary outcome measures will be according to the scores obtained (pre and post-treatment) from the IPSS (International Prostate Symptom Score). The secondary outcome is to assess the effectiveness of ’Individualized Homoeopathic Medicines’ on the basis of the totality of symptoms and ’Pathological Simlie’ Null Hypothesis: There is no significant difference in improvement in cases of BPH treated with homoeopathic medicines selected on the basis of the totality of symptoms and pathological similie

Alternate Hypothesis: There is a significant difference in improvement in cases of BPH treated with homoeopathic medicines selected on the basis of the totality of symptoms and pathological similie

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
Male
Target Recruitment
100
Inclusion Criteria
  • All males of 40 years to 80 years of age.
  • Patients giving voluntary consent for the study.
  • Cases of Benign Prostatic Hyperplasia (ICD 10- N40) with at least 3 out of following symptoms : A.
  • Frequency B.
  • Incomplete emptying C.
  • Nocturia D.
  • Intermittency E.
  • Pain (Dysuria) G.
  • Haematuria H.
  • Straining I.
  • Retention of urine (not more than 24 hrs).
  • Pre diagnosed cases of Benign Prostatic Hyperplasia are under modern medicine treatment but have no relief seeking for homoeopathic treatment.
Exclusion Criteria
  • Cases who refuses to give informed consent for the study.
  • Cases with intolerable pain or complicated with obstruction.
  • Cases with any stricture which caused obstruction.
  • Cases without proper follow–up will be excluded from the study.
  • Cases undergone bladder surgeries 6.
  • Carcinoma of prostate 7.
  • Complete urine retention for more than 24 hours.
  • Cases having any other complications of Benign Prostatic Hyperplasia.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
According to the scores obtained (pre & post treatment) from the IPSSAccording to the scores obtained from the IPSS at every 6 weeks
Secondary Outcome Measures
NameTimeMethod
To compare the efficacy of Homoeopathic Medicines in cases of Benign Prostatic Hyperplasia on the basis of totality of symptoms & Pathological Similie12 Months

Trial Locations

Locations (1)

Dr. Girendra Pal Homoepathic Hospital and Research Center

🇮🇳

Jaipur, RAJASTHAN, India

Dr. Girendra Pal Homoepathic Hospital and Research Center
🇮🇳Jaipur, RAJASTHAN, India
Dr Hari Shankar Tiwari
Principal investigator
9664226823
harishankartiwari9838@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.